跳至主要内容
临床试验/TCTR20171119001
TCTR20171119001已完成不适用

Pharmacokinetic Study of Intravenous Colistin in Pediatric Population

-0 个研究点目标入组 20 人开始时间: 2017年11月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
-
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Years 至 18 Years(—)
性别
All

入选标准

  • Age 2-18 years old
  • Documented infection by multiple-resistant micro-organisms only susceptible to colistin or empirically treated for suspected MDR- GNR infection
  • need to receive colistin at least 72 hours
  • written informed consent

排除标准

  • creatinine clearance lower than 60 mL/min/1.73m2
  • body weight less than 10 kg
  • pregnant women

研究者

发起方
-

相似试验

已完成
4 期
A clinical trial to determine pharmacokinetics of Colistin given as injection, in subjects with hospital acquired infections caused by gram negative bacilli.
CTRI/2009/091/000252Cipla Ltd12
招募中
3 期
Comparison of intravenous colistin plus nebulized colistin against intravenous ampicillin-sulbactam plus nebulized colistin in treating ventilator associated pneumonia caused by Acinetobacter baumanniiVentilator-Associated Pneumonia due to Acinetobacter baumannii.Pneumonia due to other aerobic Gram-negative bacteria
IRCT20120703010178N18Shahid Beheshti University of Medical Sciences28
已完成
不适用
Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic studyPediatric patients infected with multi-drug resistant gram negative bacteria who need to receive intravenous colistincolistin population pharmacokineticspediatricMDROs
TCTR20180526001Principal investigator
已完成
不适用
An exploratory study of administration of colistin for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.
JPRN-UMIN000002122niversity of Tokyo Hospital Department of Hamatology and Oncology5
进行中(未招募)
1 期
Pharmacokinetic/pharmacodynamic aspects of colistin intravenous administration in critically ill patients suffering from hospital infections caused by multi-antibiotic-resistant germs and receiving continuous renal replacement therapy.Critically ill patients suffering from hospital infections caused by multi-antibiotic-resistant germs and receiving continuous renal replacement therapy.MedDRA version: 20.0Level: PTClassification code 10053840Term: Bacterial sepsisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2021-001019-95-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE20